Public Health

A Penn study shows pandemic-era telehealth eliminated inequity in the rate of Black patients making it to primary care appointments after hospitalization.

The ongoing COVID-19 crisis requires strong partnerships across every level of society, write Sen. Tim Kearney, Dr. Monica Taylor, and Dr. Azmat Husain.

The U.S. death rate from COVID-19 continues to increase daily, as the rolling seven-day average for daily COVID-19 deaths has been above 2,000 since Jan. 23.

Slammed by COVID, many U.S. hospitals have put off essential procedures. Delays are leading to consequences like heart attacks and sending people to ERs to get care.

The Biden administration said that Medicare recipients will be able to get up to eight tests a month, free of charge.

The pilot program for distributing the overdose-reversing drug is funded by a grant from the Centers for Disease Control and Prevention.

Amid the COVID-19 pandemic, the need for donated blood has risen even as opportunities to donate have fallen, leading to a significant shortage.

The district says cloth masks are no longer considered effective, and will be distributing KN95s to school staff.

The results are part of a 2019 CDC and Agency for Toxic Substances and Disease Registry study evaluating exposure to PFAS near the New Castle base.

Citing recent data from the CDC, officials in the Garden State will use all of their outreach strategies to promote boosters.

As of Jan. 26, it said, 96% of active troops have been completely vaccinated, while 3,350 soldiers have refused to get the vaccine.

The city’s health commissioner said vaccinating children under 5 will help slow the spread, and the city will be ready when federal regulators give the green light.

Many families with low incomes who want their children to keep learning remotely are losing access to a federal program that helped them pay for meals.

NPR has obtained the government's $5.3 million contract for the first 10 million courses of Paxlovid, an antiviral pill for COVID-19. Here's what's in it.

The first big hurdle was crossed when Pfizer shared its clinical trial data with the FDA. There are five more steps before this vulnerable population can be vaxxed.